Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors

Introduction Few studies have reported the outcomes of adolescents and young adults (AYAs) with chronic-phase chronic myeloid leukaemia (CML-CP) on tyrosine kinase inhibitors (TKIs).Materials and methods We retrospectively analysed the clinical features, treatment response, and long-term outcomes of...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, Maho Ishikawa, Eriko Sato, Tomoiku Takaku, Keiji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Shun Tsuchiya, Yuta Kimura, Eisaku Iwanaga, Norio Komatsu, Norio Asou, Masahiro Kizaki, Yoshihiro Hatta, Tatsuya Kawaguchi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2022-12-01
coleção:	Annals of Medicine
Assuntos:	Chronic phase chronic myeloid leukaemia adolescents and young adults tyrosine kinase inhibitors Dasatinib Nilotinib
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/07853890.2022.2069280
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!